Source author record

William Hogan

William Hogan appears in the imported research catalog. Authorship, coauthor and topic links are available while profile ownership is still unclaimed.

ResearcherUnclaimed source record

Computation and Language Applications Artificial Intelligence Computational Engineering, Finance, and Science cs.CY Machine Learning Quantitative Methods

Catalog footprint

What is connected

3works

7topics

4close collaborators

Actions

Connect this record

Open graph Browse works

Inspect adjacent papers, topics, institutions and collaborators without losing the researcher page.

Building this map preview

BZPEER is loading the nearby papers, people, topics and institutions for this page.

preprint2022arXiv

An Overview of Distant Supervision for Relation Extraction with a Focus on Denoising and Pre-training Methods

Relation Extraction (RE) is a foundational task of natural language processing. RE seeks to transform raw, unstructured text into structured knowledge by identifying relational information between entity pairs found in text. RE has numerous uses, such as knowledge graph completion, text summarization, question-answering, and search querying. The history of RE methods can be roughly organized into four phases: pattern-based RE, statistical-based RE, neural-based RE, and large language model-based RE. This survey begins with an overview of a few exemplary works in the earlier phases of RE, highlighting limitations and shortcomings to contextualize progress. Next, we review popular benchmarks and critically examine metrics used to assess RE performance. We then discuss distant supervision, a paradigm that has shaped the development of modern RE methods. Lastly, we review recent RE works focusing on denoising and pre-training methods.

preprint2021arXiv

Applications of artificial intelligence in drug development using real-world data

The US Food and Drug Administration (FDA) has been actively promoting the use of real-world data (RWD) in drug development. RWD can generate important real-world evidence reflecting the real-world clinical environment where the treatments are used. Meanwhile, artificial intelligence (AI), especially machine- and deep-learning (ML/DL) methods, have been increasingly used across many stages of the drug development process. Advancements in AI have also provided new strategies to analyze large, multidimensional RWD. Thus, we conducted a rapid review of articles from the past 20 years, to provide an overview of the drug development studies that use both AI and RWD. We found that the most popular applications were adverse event detection, trial recruitment, and drug repurposing. Here, we also discuss current research gaps and future opportunities.

preprint2012arXiv

Bayesian Biosurveillance of Disease Outbreaks

Early, reliable detection of disease outbreaks is a critical problem today. This paper reports an investigation of the use of causal Bayesian networks to model spatio-temporal patterns of a non-contagious disease (respiratory anthrax infection) in a population of people. The number of parameters in such a network can become enormous, if not carefully managed. Also, inference needs to be performed in real time as population data stream in. We describe techniques we have applied to address both the modeling and inference challenges. A key contribution of this paper is the explication of assumptions and techniques that are sufficient to allow the scaling of Bayesian network modeling and inference to millions of nodes for real-time surveillance applications. The results reported here provide a proof-of-concept that Bayesian networks can serve as the foundation of a system that effectively performs Bayesian biosurveillance of disease outbreaks.